Pathology of the
pancreas
Dr. Wangari Wambugu
ANATOMY & HISTOLOGY OF THE
P A N C R E A S
 15 cm in length, 60-140 gm, consists of head, body &
tail; pancreatic duct empty into duodenum or common
bile duct
 Histologically, consists of 2 components:
– 1) Exocrine: 80-85%, consists of numerous glands
(acini) lined by columnar basophilic cells
containing zymogen granules, which form lobules;
ductal system
 Trypsin, chemotrypsin, aminopeptidase,
amylase, lipase
– 2) Endocrine: islets of Langerhans, which are
invaded by capillaries. Islets consist of:
 4 main cell types: B (insulin), A (glucagon), D
(somatostatin), PP cells (pancreatic polypeptide)
 2 minor cell types: D1 (VIP) & enterochromaffin
cells (serotonin)
Pathology
 Congenital anomalies
 Diseases of the exocrine pancreas
– Cystic fibrosis
– Acute pancreatitis
– Chronic pancreatitis
– Pancreatic carcinoma
CONGENITAL ANOMALIES
 Agenesis: usually associated with widespread
severe malformations that are incompatible
with life
 Hypoplasia: both endocrine & exocrine
elements may be involved
 Annular pancreas: pancreas head encircle
duodenum & may cause obstruction
 Aberrant (ectopic) pancreas: 2%; mostly in
stomach, duodenum, jejunum, Meckel’s
diverticulum & ileum
 Ducts anomalies: duct of Wirsung may drain
into common bile duct or an orifice high in the
duodenum
C Y S T I C F I B R O S I S
 CF is the most common lethal genetic disease
that affects white populations (1 in 2000 live
births)
 Characterized by abnormally viscid mucous
secretions that block airways & pancreatic
ducts & are responsible for:
– 1) Recurrent chronic pulmonary infections
– 2) Pancreatic insufficiency
 High level of NaCl in sweat
 Pathogenesis: primary defect in transport of
Cl
_
across epithelia. The cAMP-dependent Cl
_
channels (CF transmembrane conductance
regulator [CFTR]) are defective.
C Y S T I C F I B R O S I S
 CF gene is located on chromosome 7 with up to 300
mutations identified in this gene so far.
 Pancreatic pathology: abnormalities are seen in 85%
of patients:
– mucus accumulation,
– duct dilation & plugging,
– exocrine gland atrophy. Islets usually spared.
– Ducts may be converted into cysts separated only
by islets of Langerhans & fibrous stroma
(fibrocystic disease of pancreas)
– Malabsorption syndrome: particularly fat
– Squamous metaplasia of duct lining
 Meconium ileus, pulmonary problems
 Rx: gene therapy
ACUTE PANCREATITIS
 Inflammation of the pancreas, which is almost always
associated with acinar cell injury
 A clinical & histologic spectrum of severity &
duration
 Etiologic factors:
– Metabolic: alcohol, hyperlipoproteinemia,
hypercalcemia, drugs (e.g. thiazides), genetic
– Mechanical: gallstones, traumatic & perioperative
injury
– Vascular: shock, atheroembolism, polyarteritis
nodosa
– Infections: Mumps, Coxsackie virus, Mycoplasma
– Idiopathic : 10-20% ; ? Genetic basis
ACUTE PANCREATITIS
 Pathology:
4 basic alterations:
1) Proteolytic destruction of pancreatic
substance
2) Necrosis of blood vessels & interstitial
hemorrhage
3) Fat necrosis by lipolytic enzymes
4) Associated acute inflammatory reaction
– Pathologic lesions:
 Acute pancreatic necrosis
 Acute hemorrhagic pancreatitis
 Suppurative peritonitis
 Pancreatic pseudocysts
ACUTE PANCREATITIS
 Pathogenesis:
– Autodigestion of pancreatic tissue by
inappropriately activated pancreatic enzymes
– Trypsin has a major role:
 Activates other proenzymes (proelastase ,
prophospholipase )
 Converts prekallikrein to kallikrein (Kinin
system)
 Hageman factor is activated
– Mechanisms of pancreatic enzyme activation:
 Pancreatic duct obstruction
 Primary acinar cell injury
 Defective intracellular transport of proenzymes
within acinar cells
ACUTE PANCREATITIS
 Clinical features:
– Abdominal pain is the cardinal manifestation:
epigastric, radiating to back, variable in severity
– Shock: due to pancreatic hemorrhage & release
of vasodilatory agents
– Lab:  serum amylase and lipase;  Ca;
 bilirubin,  glucose & glycosuria
 CT scan: inflammation, pseudocysts
 Px: severe cases have high mortality rate (20-40%)
 Death due to: 1) shock, 2) secondary abdominal
sepsis, 3) adult respiratory distress syndrome
CHRONIC PANCREATITIS
 Repeated bouts of mild to moderate pancreatic
inflammation, with continued loss of pancreatic
parenchyma & replacement by fibrous tissue
 Distinction from acute pancreatitis may be difficult;
distinction is made if there is evidence of previous
attacks
 Middle-aged men, mostly in alcoholics but may due
to biliary tract disease, hyperlipoproteinemia &
hypercalcemia; no apparent cause in 50% of cases
 Pathogenesis:
– Protein hypersecretion from acinar cells
– Precipitation of proteins forming ductal plugs
– Plugs enlarge forming laminar aggregates
CHRONIC PANCREATITIS
 Pathology:
– Hard organ with dilated ducts & calcified
concretions
– Fibrosis, chronic inflammatory cells, obstruction
of ducts by protein plugs
– Extensive atrophy of exocrine glands
– Pseudocysts
 Clinical features:
– Repeated attacks of abdominal pain or may be
silent
 Dx: clinical suspicion, lab & CT
 Px: chronic disabling disease due to its major
complications: pancreatic insufficiency & diabetes
mellitus
PANCREATIC CARCINOMA
 Malignant epithelial neoplasm of exocrine
portion of pancreas
 5th most frequent cause of death from cancer
 Increasing in incidence in the West
 Peak incidence: 60 - 80 years
 Cause is unknown; more frequent in smokers
 Location:
– Head of pancreas 60%
– Body of pancreas 15%
– Tail of pancreas 5%
– Diffuse involvement 20%
PANCREATIC CARCINOMA
 Risk factors
– Smoking
– Industrial exposure to β-Naphthylamine,
benzidine
– M>F
– Genetic susceptibility
PANCREATIC CARCINOMA
 Gritty gray hard masses
 Vast majority are adenocarcinomas, with poorly
formed glands and densely fibrous stroma
 Carcinoma of pancreatic head: invasion of
ampullary region with bile outflow obstruction,
& distension of biliary tree
 Carcinoma of body & tail: no impingement on
biliary tract & remain silent for longer periods
 Extends into retroperitoneal spaces, infiltrate
nerves, abdominal organs & lymph nodes
 Distant metastasis to lungs, bone, ..
PANCREATIC CARCINOMA
 Clinical features:
– Usually silent until its extension impinges
on other structures
– Pain is usually the first symptom
– Obstructive jaundice
– Trousseau’s syndrome: Migratory
thrombophlebitis (phlebothrombosis)
 Lab: tumor markers, e.g. CEA, CA19-9 Ag are
nonspecific
 Dx: CT scan & percutaneous biopsy
 Px: 1 year survival is 10%; 5 yr survival is 2.5%

Pathology of Pancreas- notes based on robbins

  • 1.
  • 2.
    ANATOMY & HISTOLOGYOF THE P A N C R E A S  15 cm in length, 60-140 gm, consists of head, body & tail; pancreatic duct empty into duodenum or common bile duct  Histologically, consists of 2 components: – 1) Exocrine: 80-85%, consists of numerous glands (acini) lined by columnar basophilic cells containing zymogen granules, which form lobules; ductal system  Trypsin, chemotrypsin, aminopeptidase, amylase, lipase – 2) Endocrine: islets of Langerhans, which are invaded by capillaries. Islets consist of:  4 main cell types: B (insulin), A (glucagon), D (somatostatin), PP cells (pancreatic polypeptide)  2 minor cell types: D1 (VIP) & enterochromaffin cells (serotonin)
  • 3.
    Pathology  Congenital anomalies Diseases of the exocrine pancreas – Cystic fibrosis – Acute pancreatitis – Chronic pancreatitis – Pancreatic carcinoma
  • 4.
    CONGENITAL ANOMALIES  Agenesis:usually associated with widespread severe malformations that are incompatible with life  Hypoplasia: both endocrine & exocrine elements may be involved  Annular pancreas: pancreas head encircle duodenum & may cause obstruction  Aberrant (ectopic) pancreas: 2%; mostly in stomach, duodenum, jejunum, Meckel’s diverticulum & ileum  Ducts anomalies: duct of Wirsung may drain into common bile duct or an orifice high in the duodenum
  • 6.
    C Y ST I C F I B R O S I S  CF is the most common lethal genetic disease that affects white populations (1 in 2000 live births)  Characterized by abnormally viscid mucous secretions that block airways & pancreatic ducts & are responsible for: – 1) Recurrent chronic pulmonary infections – 2) Pancreatic insufficiency  High level of NaCl in sweat  Pathogenesis: primary defect in transport of Cl _ across epithelia. The cAMP-dependent Cl _ channels (CF transmembrane conductance regulator [CFTR]) are defective.
  • 7.
    C Y ST I C F I B R O S I S  CF gene is located on chromosome 7 with up to 300 mutations identified in this gene so far.  Pancreatic pathology: abnormalities are seen in 85% of patients: – mucus accumulation, – duct dilation & plugging, – exocrine gland atrophy. Islets usually spared. – Ducts may be converted into cysts separated only by islets of Langerhans & fibrous stroma (fibrocystic disease of pancreas) – Malabsorption syndrome: particularly fat – Squamous metaplasia of duct lining  Meconium ileus, pulmonary problems  Rx: gene therapy
  • 8.
    ACUTE PANCREATITIS  Inflammationof the pancreas, which is almost always associated with acinar cell injury  A clinical & histologic spectrum of severity & duration  Etiologic factors: – Metabolic: alcohol, hyperlipoproteinemia, hypercalcemia, drugs (e.g. thiazides), genetic – Mechanical: gallstones, traumatic & perioperative injury – Vascular: shock, atheroembolism, polyarteritis nodosa – Infections: Mumps, Coxsackie virus, Mycoplasma – Idiopathic : 10-20% ; ? Genetic basis
  • 9.
    ACUTE PANCREATITIS  Pathology: 4basic alterations: 1) Proteolytic destruction of pancreatic substance 2) Necrosis of blood vessels & interstitial hemorrhage 3) Fat necrosis by lipolytic enzymes 4) Associated acute inflammatory reaction – Pathologic lesions:  Acute pancreatic necrosis  Acute hemorrhagic pancreatitis  Suppurative peritonitis  Pancreatic pseudocysts
  • 12.
    ACUTE PANCREATITIS  Pathogenesis: –Autodigestion of pancreatic tissue by inappropriately activated pancreatic enzymes – Trypsin has a major role:  Activates other proenzymes (proelastase , prophospholipase )  Converts prekallikrein to kallikrein (Kinin system)  Hageman factor is activated – Mechanisms of pancreatic enzyme activation:  Pancreatic duct obstruction  Primary acinar cell injury  Defective intracellular transport of proenzymes within acinar cells
  • 14.
    ACUTE PANCREATITIS  Clinicalfeatures: – Abdominal pain is the cardinal manifestation: epigastric, radiating to back, variable in severity – Shock: due to pancreatic hemorrhage & release of vasodilatory agents – Lab:  serum amylase and lipase;  Ca;  bilirubin,  glucose & glycosuria  CT scan: inflammation, pseudocysts  Px: severe cases have high mortality rate (20-40%)  Death due to: 1) shock, 2) secondary abdominal sepsis, 3) adult respiratory distress syndrome
  • 15.
    CHRONIC PANCREATITIS  Repeatedbouts of mild to moderate pancreatic inflammation, with continued loss of pancreatic parenchyma & replacement by fibrous tissue  Distinction from acute pancreatitis may be difficult; distinction is made if there is evidence of previous attacks  Middle-aged men, mostly in alcoholics but may due to biliary tract disease, hyperlipoproteinemia & hypercalcemia; no apparent cause in 50% of cases  Pathogenesis: – Protein hypersecretion from acinar cells – Precipitation of proteins forming ductal plugs – Plugs enlarge forming laminar aggregates
  • 17.
    CHRONIC PANCREATITIS  Pathology: –Hard organ with dilated ducts & calcified concretions – Fibrosis, chronic inflammatory cells, obstruction of ducts by protein plugs – Extensive atrophy of exocrine glands – Pseudocysts  Clinical features: – Repeated attacks of abdominal pain or may be silent  Dx: clinical suspicion, lab & CT  Px: chronic disabling disease due to its major complications: pancreatic insufficiency & diabetes mellitus
  • 19.
    PANCREATIC CARCINOMA  Malignantepithelial neoplasm of exocrine portion of pancreas  5th most frequent cause of death from cancer  Increasing in incidence in the West  Peak incidence: 60 - 80 years  Cause is unknown; more frequent in smokers  Location: – Head of pancreas 60% – Body of pancreas 15% – Tail of pancreas 5% – Diffuse involvement 20%
  • 20.
    PANCREATIC CARCINOMA  Riskfactors – Smoking – Industrial exposure to β-Naphthylamine, benzidine – M>F – Genetic susceptibility
  • 21.
    PANCREATIC CARCINOMA  Grittygray hard masses  Vast majority are adenocarcinomas, with poorly formed glands and densely fibrous stroma  Carcinoma of pancreatic head: invasion of ampullary region with bile outflow obstruction, & distension of biliary tree  Carcinoma of body & tail: no impingement on biliary tract & remain silent for longer periods  Extends into retroperitoneal spaces, infiltrate nerves, abdominal organs & lymph nodes  Distant metastasis to lungs, bone, ..
  • 23.
    PANCREATIC CARCINOMA  Clinicalfeatures: – Usually silent until its extension impinges on other structures – Pain is usually the first symptom – Obstructive jaundice – Trousseau’s syndrome: Migratory thrombophlebitis (phlebothrombosis)  Lab: tumor markers, e.g. CEA, CA19-9 Ag are nonspecific  Dx: CT scan & percutaneous biopsy  Px: 1 year survival is 10%; 5 yr survival is 2.5%